HDL biology
Short-term hypothyroidism significantly lowers serum CETP concentration but not activity, decoupled from HDL2:HDL3 and LDL-cholesterol correlations seen in controls (Clin Endocrinol 2003)
Original title: Low cholesteryl ester transfer protein (CETP) concentration but normal CETP activity in serum from patients with short-term hypothyroidism Lack of relationship to lipoprotein abnormalities
Sixty-six thyroidectomized patients were withdrawn from L-thyroxine (L-T4) treatment for 5 weeks, then had L-T4 reinstated for 2 months, and were compared with 61 matched normolipidaemic controls for serum cholesteryl ester transfer protein (CETP) activity and mass, and lipoprotein size. Serum CETP mass was significantly lower in short-term hypothyroid patients than controls (3.22 +/- 0.98 versus 3.79 +/- 1.2 mg/l; P < 0.001) and normalized during L-T4 therapy, while the ability of endogenous lipoproteins to interact with CETP remained normal. HDL size distribution differed significantly in hypothyroid patients, with higher proportions of large HDL2b (13.6 +/- 6.5% before versus 8.5 +/- 4.2% during L-T4 therapy; P < 0.05). While CETP mass correlated negatively with the HDL2-to-HDL3 ratio (r = -0.588; P < 0.0001) and positively with LDL cholesterol (r = 0.264; P < 0.05) in controls, neither correlation was significant in hypothyroid patients.
Original abstract
Objectives: Hypothyroidism is associated with a number of abnormalities in lipoprotein metabolism. Although alterations in neutral lipid exchanges among plasma lipoproteins might be one characteristic feature of hypothyroidism, a few human studies of cholesteryl ester transfer protein (CETP) activity have led to heterogeneous and fragmentary observations. The aim of the present study was to analyse the influence of short-term hypothyroidism on CETP activity, as well as on the structure and composition of lipoproteins. PATIENTS, DESIGN AND MEASUREMENTS: Sixty-six thyroidectomized patients were withdrawn from L-thyroxine (L-T4) treatment for 5 weeks. Subsequently, L-T4 therapy was reinstated for 2 months and patients were compared to 61 matched normolipidaemic controls. Serum CETP activity and mass concentration, serum lipids, apolipoproteins and lipoprotein size distribution were determined in the three groups.
Results: Serum CETP mass concentration was significantly decreased in short-term hypothyroid patients, as compared to control subjects (3.22 +/- 0.98 vs. 3.79 +/- 1.2 mg/l, respectively; P < 0.001), and the values were normalized during L-T4 therapy. The ability of endogenous serum lipoproteins to interact with CETP was normal in short-term hypothyroid patients. Concordant observations were made regardless of whether neutral lipid transfers were measured from high-density lipoproteins (HDL) toward apo B-containing lipoproteins or from liposomes toward HDL. The size distribution of HDL was significantly different in short-term hypothyroid patients, compared to either the control or treated subgroups, with significant higher proportions of large-sized HDL2b and HDL2a (HDL2b: 13.6 +/- 6.5% before vs. 8.5 +/- 4.2% during L-T4 therapy, P < 0.05; HDL2a, 33.0 +/- 7.0% before vs. 29.3 +/- 6.9% during L-T4 therapy, P < 0.05). Although serum CETP mass concentration correlated negatively with the HDL2 to HDL3 ratio in control subjects (r = -0.588; P < 0.0001), no significant correlations were observed in hypothyroid patients, regardless of whether they were treated or not. Similarly, whereas the previously recognized positive correlation of CETP mass concentration with serum LDL cholesterol levels was found in control subjects (r = 0.264; P < 0.05), no significant correlations appeared in treated and untreated patients.
Conclusions: Short-term hypothyroidism may constitute an unique situation in which concomitant alterations in serum cholesteryl ester transfer protein concentration and lipoprotein parameters are disconnected.
Summary written by cetpinhibition.org from the published abstract; figures as published. Page updated 19 August 2026. Methods.